Ministry health

Thai Ministry of Health buys COVID antibodies from AstraZeneca

Anutin said that previously the DDC purchased the COVID-19 virus vector vaccine from AstraZeneca to develop immunity among the local population, however, some groups of vaccinees were unable to develop immunity or lost their antibodies rapidly. and therefore risked serious illness or death after infection, he said.

Public Health Minister Anutin Charnvirakul attended a contract signing ceremony where the Public Health Ministry agreed to purchase long-acting antibodies (LAAB) from AstraZeneca to protect immunocompromised patients against COVID-19.

Mr Anutin said that previously, the Department of Disease Control of the Ministry of Public Health purchased the COVID-19 viral vector vaccine from AstraZeneca to build immunity among the local population.

However, some groups of vaccinees were unable to develop immunity or lost their antibodies quickly and therefore risked serious illness or death after infection, he said. The Minister referred to people with chronic kidney disease and those who received immunosuppressive agents after their organ or bone marrow transplant.

Therefore, the COVID-19 Situation Administration Center instructed the Ministry of Public Health to procure LAAB to help vulnerable groups of people, he said.

The contract signed was for the purchase of approximately 250,000 doses. It did not require additional budget because the purchase would replace some of the COVID-19 vaccine doses previously ordered from AstraZeneca, Mr Anutin said.

He expected the first batch of 7,000 doses of LAAB to be delivered during this month. (TNA)


Previous postCOVID-19 vaccine guidelines for travelers to Thailand in July